all report title image
  • Published On : Mar 2022
  • Code : CMI4753
  • Industry : Medical Devices
  • Pages : 228
  • Formats :

For the isolation, identification, and characterization of bacterial and viral agents, proper collection and transport of clinical specimens are critical. It is essential to comply with the required biosafety guidelines when dealing with potentially infectious clinical specimens to maintain a safe working environment for health care workers, patients, and laboratorians. Infection may spread from staff to patient or from patient to staff at the time of carrying out the collection procedure. Whenever possible, all culture specimens must be collected prior to the administration of any antimicrobial agents.

The global bacterial & viral specimen collection market is estimated to be valued at US$ 17,667.8 Million in 2021 and is expected to exhibit a CAGR of 13.6% during the forecast period (2021-2028).

Figure 1. Global Bacterial & Viral Specimen Collection Market Share (%), by Product Type, 2021

Bacterial And Viral Specimen Collection  | Coherent Market Insights

Increasing prevalence of bacterial and viral diseases is expected to drive the market growth during the forecast period.

The increasing number of bacterial and viral diseases such as the COVID-19, syphilis, and others is expected to drive the global bacterial & viral specimen collection market growth over the forecast period. For instance, according to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization (WHO), over 278.64 million cases and 5.4 million deaths due to coronavirus disease were reported till December 24, 2021, across the globe.

CMI table icon

Bacterial & Viral Specimen Collection Market Report Coverage

Report Coverage Details
Base Year: 2020 Market Size in 2021: US$ 17,667.8 Mn
Historical Data for: 2017 to 2020 Forecast Period: 2021 to 2028
Forecast Period 2021 to 2028 CAGR: 13.6% 2028 Value Projection: US$ 43,260.8 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Bacterial Specimen Collection (Swabs, Bacterial Transport Media, Sample Collection Kits, Others), Viral Specimen Collection (Swabs, Viral Transport Media, Sample Collection Kits, Others)
  • By Application: Diagnostics, Research
  • By End User: Hospitals, Diagnostic Laboratories, Academic and Research Institution, Others 
Companies covered:

Thermo Fisher Scientific Inc., Quidel Corporation, Puritan Medical Products, Becton, Dickinson and Company, COPAN Diagnostics Inc., Longhorn Vaccines and Diagnostics LLC, Medical Wire & Equipment, Trinity Biotech PLC, HiMedia Laboratories Pvt. Ltd., Hardy Diagnostics, Wuxi NEST Biotechnology Co., Ltd., VIRCELL S.L., DiaSorin S.P.A., Titan Biotech Ltd., Pretium Packaging L.L.C., and Spectrum Solutions L.L.C.

Growth Drivers:
  • High prevalence of bacterial and viral diseases such as tuberculosis, COVID-19, and others
  • Strong focus of market players on strategic collaborations
  • Rising research and development activities 
Restraints & Challenges:
  • Limitations of bio specimen collection such as false positive/negative results and others 

Figure 2. Global Bacterial & Viral Specimen Collection Market Share (%), by Application, 2021

Bacterial And Viral Specimen Collection  | Coherent Market Insights

Increasing launches of bacterial & viral specimen collection kits, transport media, and others are expected to drive the market growth during the forecast period.

Increasing launches of bacterial & viral specimen collection kits, swabs, transport media, and others are expected to fuel the global bacterial & viral specimen collection market growth over the forecast period. For instance, in November 2021, VIRCELL S.L., a microbial biotechnology company, announced the launch of a new transport medium for the collection and preservation of chlamydia, viruses, and mycoplasma, incorporating a flocked swab intended for use in pediatric patients. This new transport medium is suitable for COVID-19 testing using pharyngeal and nasopharyngeal samples.

Global Bacterial & Viral Specimen Collection Market – Impact of Coronavirus (COVID-19) Pandemic

Lockdown or shutdown due to the COVID-19 was imposed in various countries, which had a negative impact on the economy of the private healthcare sector all around the world. This lockdown resulted in the closure of industrial establishments, except the manufacturing of essential commodities, and disruption in the supply chain of products. Supply chain and manufacturing activities in countries such as the U.S., the U.K., India, China, United Arab Emirates, and others have been disrupted due to the lockdown. Additionally, countries such as Thailand, Indonesia, Singapore, and others are facing problems with the transportation of raw materials.

However, the demand for bacterial and viral specimen collection products is expected to increase during the COVID-19 pandemic, owing to the rising number of COVID-19 cases. Moreover, strong focus of market players on launching and receiving regulatory approvals for producing safe and effective COVID-19 specimen collection kits and others is expected to fuel the global bacterial & viral specimen collection market growth. For instance, in December 2020, Ellume, an Australia-based medical technology company, received authorization from the U.S. Food and Drug Administration (FDA) for the emergency use of its at-home nasal swab diagnostic test for the COVID-19. This test is the first over-the-counter (OTC) diagnostic test that can be performed at home without the aid of any health professional.

Global Bacterial & Viral Specimen Collection Market: Restraint

The major factors that hinder the global bacterial & viral specimen collection market growth include the limitations of bio specimen collection such as false positive/negative results and others. For instance, on April 17, 2020, the Washington State Department of Health was informed by UW Medicine that the procured batch of COVID-19 specimen collection kits may have quality control issues due to which the Washington State Department of Health recalled around 12,000 kits sent to tribal nations, local health jurisdictions, and state agency partners across the U.S.

Key Players

Major players operating in the global bacterial & viral specimen collection market include Thermo Fisher Scientific Inc., Quidel Corporation, Puritan Medical Products, Becton, Dickinson and Company, COPAN Diagnostics Inc., Longhorn Vaccines and Diagnostics LLC, Medical Wire & Equipment, Trinity Biotech PLC, HiMedia Laboratories Pvt. Ltd., Hardy Diagnostics, Wuxi NEST Biotechnology Co., Ltd., VIRCELL S.L., DiaSorin S.P.A., Titan Biotech Ltd., Pretium Packaging L.L.C., and Spectrum Solutions L.L.C.

The accuracy and interpretation of microbiological results depend, to a great extent, on the quality of the samples and their processing in the microbiology laboratory. The suitable time to collect the sample, type of specimen, method of sampling, its storage, and transport are essential points in the diagnostic process. In order to obtain accurate, clinically relevant, and significant results by the microbiology department, it is essential to rightly select, collect, and transport all microbiological samples. In recent years, automated equipment has evolved for a number of rapid diagnostic techniques of the immunological type, seeding of the samples, and for the identification of antigens.

Market Dynamics

Increasing research and development activities is expected to drive the global bacterial & viral specimen collection market growth over the forecast period. For instance, according to an article published by the National Institutes of Health (NIH), U.S. in July 2020, Helix OpCo, LLC, a California-based population genomic company, developed standardized nasal swab kits in bulk for the collection of nasal secretion samples to detect SARS-CoV-2. This will allow the processing of thousands of nasal swab samples at once and provide results within 24-48 hours. These COVID-19 nasal swab kits can be used by the public health departments, employers, healthcare systems, and others globally.

Key features of the study:

  • This report provides an in-depth analysis of the global bacterial & viral specimen collection market, market size (US$ Million, and compound annual growth rate (CAGR%) for the forecast period (2021–2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global bacterial & viral specimen collection market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Thermo Fisher Scientific Inc., Quidel Corporation, Puritan Medical Products, Becton, Dickinson and Company, COPAN Diagnostics Inc., Longhorn Vaccines and Diagnostics LLC, Medical Wire & Equipment, Trinity Biotech PLC, HiMedia Laboratories Pvt. Ltd., Hardy Diagnostics, Wuxi NEST Biotechnology Co., Ltd., VIRCELL S.L., DiaSorin S.P.A., Titan Biotech Ltd., Pretium Packaging L.L.C., and Spectrum Solutions L.L.C.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global bacterial & viral specimen collection market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bacterial & viral specimen collection market

Detailed Segmentation:

  • Global Bacterial & Viral Specimen Collection Market, By Product Type:
    • Bacterial Specimen Collection
      • Swabs
      • Bacterial Transport Media
      • Sample Collection Kits
      • Others
    • Viral Specimen Collection
      • Swabs
      • Viral Transport Media
      • Sample Collection Kits
      • Others
  • Global Bacterial & Viral Specimen Collection Market, By Application:
    • Diagnostics
    • Research
  • Global Bacterial & Viral Specimen Collection Market, By End User:
    • Hospitals
    • Diagnostic Laboratories
    • Academic and Research Institution
    • Others
  • Global Bacterial & Viral Specimen Collection Market, By Region:
    • North America
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Country
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • By Country
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Region/Country
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Thermo Fisher Scientific Inc.*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Quidel Corporation
    • Puritan Medical Products
    • Becton, Dickinson and Company
    • COPAN Diagnostics Inc.
    • Longhorn Vaccines and Diagnostics LLC
    • Medical Wire & Equipment
    • Trinity Biotech PLC
    • HiMedia Laboratories Pvt. Ltd.
    • Hardy Diagnostics
    • Wuxi NEST Biotechnology Co., Ltd.
    • VIRCELL S.L.
    • DiaSorin S.P.A.
    • Titan Biotech Ltd.
    • Pretium Packaging L.L.C
    • Spectrum Solutions L.L.C.

 “*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

The global bacterial & viral specimen collection market size is estimated to be valued at US$ 17,667.8 Million in 2021 and expected to exhibit a CAGR of 13.6% between 2021 and 2028.
Factors such as the high prevalence of bacterial and viral diseases such as tuberculosis, COVID-19, and others, strong focus of market players on strategic collaborations, and significant growth in research and development activities are expected to drive the market growth during forecast period.
Bacterial Specimen Collection is the leading product type segment in the market.
The major factors hampering the growth of the market include the limitations of bio specimen collection such as false positive/negative results and others.
Major players operating in the market include Thermo Fisher Scientific Inc., Quidel Corporation, Puritan Medical Products, Becton, Dickinson and Company, COPAN Diagnostics Inc., Longhorn Vaccines and Diagnostics LLC, Medical Wire & Equipment, Trinity Biotech PLC, HiMedia Laboratories Pvt. Ltd., Hardy Diagnostics, Wuxi NEST Biotechnology Co., Ltd., VIRCELL S.L., DiaSorin S.P.A., Titan Biotech Ltd., Pretium Packaging L.L.C., and Spectrum Solutions L.L.C.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo